Neurocrine Biosciences shares owned by Linden Thomas Advisory Services
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Linden Thomas Advisory Services
from 13F filings
Historical chart of Linden Thomas Advisory Services investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Linden Thomas Advisory Services consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Linden Thomas Advisory Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $961k | 6.8k | 140.38 |
| 2025-06-30 | $842k | 6.7k | 125.69 |
| 2025-03-31 | $730k | 6.6k | 110.60 |
| 2024-12-31 | $867k | 6.4k | 136.50 |
| 2024-09-30 | $698k | 6.1k | 115.22 |
| 2024-06-30 | $798k | 5.8k | 137.67 |
| 2024-03-31 | $933k | 6.8k | 137.92 |
| 2023-12-31 | $851k | 6.5k | 131.76 |
| 2023-09-30 | $701k | 6.2k | 112.50 |
| 2023-06-30 | $1.5M | 16k | 94.30 |
| 2023-03-31 | $1.6M | 15k | 101.22 |
| 2022-12-31 | $1.8M | 15k | 119.44 |
More positions owned by Linden Thomas Advisory Services
View all positions for Linden Thomas Advisory Services